Oncology

An artificial intelligence tool trained on digital pathology slides has demonstrated clinical-grade accuracy for detecting EGFR mutations in lung adenocarcinoma and significantly reduced reliance on molecular testing, according to results from a large-scale real-world deployment study.

Modulating the gut microbiome may enhance immunotherapy responses in patients with solid tumors, according to a recent review exploring emerging evidence across melanoma, renal cell carcinoma (RCC), and non-small cell lung cancer (NSCLC).

Disparities in the use of patient portal messaging remain prevalent among oncology patients, even among those who are already enrolled, according to a large retrospective study from an urban academic cancer center.

Sexual health problems are highly prevalent and distressing among breast cancer survivors, yet the majority of women report receiving little to no support from their healthcare teams, according to findings from the WISH-BREAST survey.

A nationwide study of basal cell carcinoma (BCC) excisions in Denmark found that hospital-based specialists have significantly lower odds of incomplete removal than their practice-based peers, raising important questions about treatment setting and provider expertise.

A 15-year retrospective study from southeastern Romania has revealed a high mortality burden associated with HIV-related lymphomas, underscoring the critical need for earlier diagnosis and integrated treatment strategies.

Metformin use linked to significantly lower colorectal cancer risk in patients with inflammatory bowel disease, according to a new population-based cohort study.

A new randomized study finds that integrating breast density and polygenic risk scores (PRS) into breast cancer risk assessments significantly alters individual risk estimates and may influence future screening strategies.